Hm Payson & CO Danaher Corp Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Danaher Corp stock. As of the latest transaction made, Hm Payson & CO holds 132,098 shares of DHR stock, worth $30.8 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

132,098

Previous 136,806 3.44%

Holding current value

$30.8 Million

Previous $34.2 Million 7.43%

% of portfolio

0.63%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$239.25 - $280.76 $1.13 Million - $1.32 Million	-4,708 Reduced 3.44%	132,098 $36.7 Million
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $524,245 - $596,523	-2,226 Reduced 1.6%	136,806 $34.2 Million
Q1 2024 Jun 20, 2024	SELL	$224.58 - $256.19 $925,943 - $1.06 Million	-4,123 Reduced 2.88%	139,032 $34.7 Million
Q4 2023 Feb 13, 2024	SELL	$185.1 - $233.13 $3.14 Million - $3.96 Million	-16,976 Reduced 10.6%	143,155 $33.1 Million
Q3 2023 Nov 06, 2023	SELL	$233.08 - $265.59 $14.9 Million - $17 Million	-63,924 Reduced 28.53%	160,131 $39.7 Million
Q2 2023 Jul 17, 2023	SELL	$224.99 - $256.14 $309,361 - $352,192	-1,375 Reduced 0.61%	224,055 $53.8 Million
Q1 2023 Apr 18, 2023	BUY	$239.75 - $277.0 $338,527 - $391,124	1,412 Added 0.63%	225,430 $56.8 Million
Q4 2022 Feb 06, 2023	BUY	$241.42 - $282.29 $3.29 Million - $3.85 Million	13,631 Added 6.48%	224,018 $59.5 Million
Q3 2022 Oct 25, 2022	BUY	$247.06 - $1507.4 $2.74 Million - $16.7 Million	11,079 Added 5.56%	210,387 $54.3 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $625,496 - $790,503	2,638 Added 1.34%	199,308 $50.5 Million
Q1 2022 May 12, 2022	BUY	$257.27 - $315.76 $57,885 - $71,046	225 Added 0.11%	196,670 $57.7 Million
Q4 2021 Feb 15, 2022	BUY	$292.08 - $329.01 $466,159 - $525,099	1,596 Added 0.82%	196,445 $64.6 Million
Q3 2021 Nov 30, 2021	SELL	$272.21 - $332.43 $589,879 - $720,375	-2,167 Reduced 1.1%	194,849 $59.3 Million
Q2 2021 Aug 17, 2021	SELL	$225.08 - $271.69 $691,445 - $834,631	-3,072 Reduced 1.54%	197,016 $52.9 Million
Q1 2021 Jun 15, 2021	SELL	$212.38 - $245.9 $48,210 - $55,819	-227 Reduced 0.11%	200,088 $45 Million
Q4 2020 Mar 10, 2021	SELL	$212.5 - $245.46 $53,762 - $62,101	-253 Reduced 0.13%	200,315 $44.5 Million
Q3 2020 Dec 21, 2020	SELL	$177.16 - $215.33 $895,012 - $1.09 Million	-5,052 Reduced 2.46%	200,568 $43.2 Million
Q2 2020 Aug 13, 2020	SELL	$128.7 - $176.83 $899,612 - $1.24 Million	-6,990 Reduced 3.29%	205,620 $36.4 Million
Q1 2020 Jul 01, 2020	SELL	$121.39 - $169.05 $218,744 - $304,628	-1,802 Reduced 0.84%	212,610 $29.4 Million
Q4 2019 Feb 18, 2020	SELL	$133.47 - $153.48 $1.69 Million - $1.94 Million	-12,663 Reduced 5.58%	214,412 $32.9 Million
Q3 2019 Nov 12, 2019	BUY	$135.4 - $146.47 $697,987 - $755,052	5,155 Added 2.32%	227,075 $32.8 Million
Q2 2019 Aug 15, 2019	BUY	$124.88 - $143.73 $397,617 - $457,636	3,184 Added 1.46%	221,920 $31.7 Million
Q1 2019 Jul 31, 2019	BUY	$97.62 - $132.29 $20.8 Million - $28.2 Million	213,109 Added 3787.26%	218,736 $28.9 Million
Q4 2018 Feb 15, 2019	SELL	$94.85 - $109.54 $15.4 Million - $17.8 Million	-162,507 Reduced 96.65%	5,627 $580,000
Q3 2018 Nov 30, 2018	SELL	$98.13 - $108.9 $6.1 Million - $6.77 Million	-62,137 Reduced 26.98%	168,134 $18.3 Million
Q2 2018 Aug 27, 2018	BUY	$96.1 - $103.24 $1.01 Million - $1.08 Million	10,504 Added 4.78%	230,271 $22.7 Million
Q1 2018 May 14, 2018	BUY	$92.16 - $103.8 $594,708 - $669,821	6,453 Added 3.03%	219,767 $21.5 Million
Q4 2017 Feb 16, 2018	BUY	$85.26 - $94.62 $455,970 - $506,027	5,348 Added 2.57%	213,314 $19.8 Million
Q3 2017 Nov 06, 2017	BUY	$79.29 - $88.45 $16.5 Million - $18.4 Million	207,966	207,966 $17.8 Million

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account